Home > Healthcare > Medical Devices > Therapeutic Devices > kyphoplasty market
Get a free sample of Kyphoplasty Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Kyphoplasty Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Kyphoplasty Market size was valued at USD 635 million in 2022 and is estimated to account for USD 1.1 billion by 2032. Kyphoplasty is a minimally invasive surgical procedure used to treat vertebral compression fractures (VCFs) in the spine, often caused by osteoporosis or spinal tumors.
The procedure involves the insertion of a balloon device into the fractured vertebra that influences to create a cavity. The cavity is filled with orthopedic bone cement and casting materials to stabilize the fractured vertebra, restore vertebral height, and alleviate pain. Thus, kyphoplasty caters as a minimally invasive alternative to standard spine surgery for patients associated with vertebral compression fractures with less pain and improve mobility, thereby increasing the adoption rate.
Moreover, the rising prevalence of osteoporosis is further augmenting the market trends. For instance, according to International Osteoporosis Foundation estimated that osteoporosis affects one in five men and one in three women aged over 50 years across the world. Moreover, more than 200 million women are estimated to be affected by osteoporosis, including one-tenth of women over 60, one-fifth of women over 70, two-fifths of women over 80, and two-thirds of women over 90. As the incidence rate of osteoporosis continues to rise globally, the demand for orthopedic devices rises, thereby increasing the number of kyphoplasty procedures, accelerating industry expansion.
The U.S. kyphoplasty market was worth USD 260.7 million in 2022 and is predicted to witness substantial growth through 2032, on account of increasing elderly populace that is more prone to conditions such as osteoporosis and vertebral fractures.
The global market for kyphoplasty was valued at USD 635 million in 2022 and is estimated to account for USD 1.1 billion by 2032, owing to growing prevalence of osteoporosis.
The bone access devices segment accounted for USD 236.7 million in 2022, backed by the increasing demand for minimally invasive procedures in the field of spine surgery.
Stryker, MicroPort Scientific Corporation, Medtronic Inc., DePuy Synthes (Johnson & Johnson Services Inc.), Smith & Nephew, IZI Medical Products, Merit Medical Systems, CareFusion, Joimax GmbH, Joline GmbH & Co. KG, G21 S.r.l., among others.